Status:
COMPLETED
Response of Desloratadine Syrup in the Relief of Symptoms Associated With Perennial Allergic Rhinitis in Pediatric Patients (Study P04299)
Lead Sponsor:
Organon and Co
Conditions:
Rhinitis
Eligibility:
All Genders
2-11 years
Brief Summary
Evaluate the safety and general clinical response of desloratadine syrup in the relief of symptoms associated with perennial allergic rhinitis in Indonesian pediatric patients.
Detailed Description
Children, ages 2-11, with a history of perennial allergic rhinitis
Eligibility Criteria
Inclusion
- Children patients of both sexes aged between 2-11 years, of either gender and any race
- Unequivocal history of perennial allergic rhinitis, including nasal congestion, sneezing, rhinorrhea, pruritus, and lacrimation
- Minimum score for inclusion: 10
- Capable of complying with the dosing regimen
- Free of any clinically significant disease (other than allergic rhinitis)
- Antihistamine must be justified by investigating doctor
Exclusion
- Patients with asthma who require chronic use of inhaled or systemic corticosteroids
- History of frequent, clinically significant sinusitis or chronic purulent postnasal drip
- Patients with rhinitis medicamentosa
- History of hypersensitivity to desloratadine or any of its excipients
- Doctor deems unsuitable
Key Trial Info
Start Date :
May 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2007
Estimated Enrollment :
591 Patients enrolled
Trial Details
Trial ID
NCT00704769
Start Date
May 1 2005
End Date
December 1 2007
Last Update
February 9 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.